Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Svensson M et al. |
Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069981
|
Giacometti A et al. |
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127075
|
Comley JC and Sterling AM |
Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785975
|
Watanabe K et al. |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561829
|
Struillou L et al. |
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785988
|
Kim JM et al. |
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561865
|
Endo H et al. |
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11709323
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Alder J et al. |
Clarithromycin therapy of experimental Treponema pallidum infections in hamsters. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8494384
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Bakker-Woudenberg IA et al. |
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917538
|
Traunmüller F et al. |
Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17606673
|
Kim YC et al. |
Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917564
|
Dega H et al. |
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234844
|
Endo H et al. |
Effects of clarithromycin and amoxicillin on gastric emptying in rats. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234874
|
Yasuda H et al. |
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239580
|
Kalach N et al. |
Clarithromycin resistance and eradication of Helicobacter pylori in children. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408237
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Rastogi N et al. |
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667250
|
Lazard T et al. |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215285
|
Koh WJ et al. |
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25987622
|
Riska PF et al. |
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328134
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Khan AA et al. |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145840
|
Collins L and Franzblau SG |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145860
|
Lounis N et al. |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145892
|
Osborne CS et al. |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19596876
|
Cavalieri SJ et al. |
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7492101
|
Bosnar M et al. |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917536
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
Lemaire S et al. |
Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19564365
|
Subramanian S et al. |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18070962
|
Tamaoki J et al. |
Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486901
|
Burton AJ et al. |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824218
|
Leuthner KD et al. |
Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16436754
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Hoffner SE et al. |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8392308
|
Zhou Z et al. |
Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25451048
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Cirioni O et al. |
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18779356
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Abduljalil K et al. |
Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19414584
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Matic V et al. |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504828
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Spyridaki A et al. |
Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22564837
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Stone GG et al. |
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9056021
|
Furuie H et al. |
Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19933801
|
de Lalla F et al. |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387303
|
Zhanel GG et al. |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18285482
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Cohen Y et al. |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1332586
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Bermudez LE et al. |
Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22615290
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Truffot-Pernot C et al. |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834015
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Atkinson BA et al. |
Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8619588
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Andini N and Nash KA |
Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16801446
|
Hsu PI et al. |
Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070099
|
van Doorn LJ et al. |
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302817
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Piccolomini R et al. |
In vitro activity of clarithromycin against intracellular Helicobacter pylori. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302831
|
Secka O et al. |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23263004
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Segreti J et al. |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952061
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Matsuzaki J et al. |
Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22203601
|
Yamaguchi H et al. |
Chlamydia pneumoniae resists antibiotics in lymphocytes. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760877
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Giamarellos-Bourboulis EJ et al. |
Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa. |
2004 |
Antimicrob. Agents Chemother. |
pmid:14693524
|
Hultén K et al. |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371366
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Welsh L et al. |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787907
|
Liu KY et al. |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24687504
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Fontana C et al. |
New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12435674
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Renvoisé A et al. |
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26324275
|
Obregón-Henao A et al. |
Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26303795
|
Nash KA |
Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506008
|
Best LM et al. |
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506021
|